 RADNOR, Pa., Aug. 26, 2021 PRNewswire -- NRx Pharmaceuticals NRx Nasdaq: NRXP announced today it has signed an agreement with Cardinal Health to provide third party logistics and distribution of ZYESAMITM upon the potential Emergency Use Authorization EUA approval by the US Food and Drug Administration FDA. 